The Metabolism and Disposition of the Oral Direct Thrombin Inhibitor, Dabigatran, in Humans

10.1016/0006-2952(95)02040-3

10.1378/chest.126.3_suppl.204S

1997, Kidney Int, 50, 886

10.1021/tx00042a018

10.1124/dmd.31.5.645

10.1111/j.1538-7836.2004.00890.x

10.1111/j.1538-7836.2004.01100.x

Fenselau C (1994) Acylgucuronides as chemically reactive intermediates, in Conjugation-Deconjugation, Reactions in Drug Metabolism and Toxicity (Kauffman FE and Bock KW eds) pp 365–389, Springer Verlag, Berlin.

1986, J Biol Chem, 261, 5051, 10.1016/S0021-9258(19)89213-X

10.1021/jm0109513

1996, Drug Metab Dispos, 24, 948

2000, Mol Pharmacol, 57, 1243

10.1016/S0378-4347(97)00603-8

10.1021/js9700558

1995, Drug Metab Dispos, 23, 154

10.1358/dof.2003.028.04.729682

10.1023/A:1013378731183

10.1177/0091270005274550

10.1111/j.1365-2125.2007.02899.x

2007, Clin Pharmacokinet, 64, 292

2001, Thromb Haemost, 86, 216

1993, J Pharmacol Exp Ther, 265, 401

10.1016/0006-2952(91)90022-W

1996, Methods Enzymol, 272, 105, 10.1016/S0076-6879(96)72013-X

10.1111/j.1538-7836.2005.01374.x

2001, Thromb Haemost, 86, 232

2001, Thromb Haemost, 85, 216

1994, Mol Pharmacol, 46, 568